Sexual Dysfunction After Renal Transplantation

Sponsor
Xijing Hospital (Other)
Overall Status
Recruiting
CT.gov ID
NCT05856929
Collaborator
(none)
500
2
20
250
12.5

Study Details

Study Description

Brief Summary

A questionnaire will be send to kidney transplant recipients to investigate characteristics of them and their sexual function, all participants in the survey are anonymous and voluntary, then analyse these characteristics.

Condition or Disease Intervention/Treatment Phase
  • Other: no Intervention

Study Design

Study Type:
Observational
Anticipated Enrollment :
500 participants
Observational Model:
Other
Time Perspective:
Cross-Sectional
Official Title:
Sexual Function and Reproductive Function of Kidney Transplant Recipients
Actual Study Start Date :
Oct 1, 2022
Anticipated Primary Completion Date :
Jan 1, 2024
Anticipated Study Completion Date :
Jun 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Renal transplant group

Other: no Intervention
no intervention

Outcome Measures

Primary Outcome Measures

  1. the number of participants is up to 500 [2024.06]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 70 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • patients who have undergone kidney transplantation for more than six months
Exclusion Criteria:
  • having no sexual partner, being under 18 or over 70 years of age, exhibiting abnormal mental behavior, having poor understanding and communication ability, having low intelligence, or having a congenital sexual disorder

Contacts and Locations

Locations

Site City State Country Postal Code
1 Xijing Hospital Xi'an Shaanxi China 710032
2 Department of Urology Xi'an China 710032

Sponsors and Collaborators

  • Xijing Hospital

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Xijing Hospital
ClinicalTrials.gov Identifier:
NCT05856929
Other Study ID Numbers:
  • KY20222236-C-1
First Posted:
May 12, 2023
Last Update Posted:
May 12, 2023
Last Verified:
Sep 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Product Manufactured in and Exported from the U.S.:
No

Study Results

No Results Posted as of May 12, 2023